Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
168 hedge funds and large institutions have $885M invested in Avid Bioservices, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 69 increasing their positions, 54 reducing their positions, and 26 closing their positions.
28% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 54
9% less funds holding
Funds holding: 184 → 168 (-16)
14% less call options, than puts
Call options by funds: $472K | Put options by funds: $546K
28% less capital invested
Capital invested by funds: $1.23B → $885M (-$343M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
46% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$30.1M |
| 2 |
State Street
Boston,
Massachusetts
|
+$19M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$9.47M |
| 4 |
AC
AltraVue Capital
Bellevue,
Washington
|
+$9.47M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$7.57M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$51.4M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$9.76M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9.19M |
| 4 |
Bessemer Group
Woodbridge,
New Jersey
|
-$6.99M |
| 5 |
MPAM
Monarch Partners Asset Management
Boston,
Massachusetts
|
-$5.09M |
CDMO Hedge Fund Activity: Q4 2022 in Review
168 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q4 2022, worth a combined $885M — down 28% from $1.23B a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of CDMO and 14 opened new positions — a net loss of 12 holders — while 54 trimmed existing stakes and 69 added.
The largest buyer was T. Rowe Price Investment Management, adding an estimated $30.1M. The largest seller was Fidelity Investments, cutting an estimated $51.4M.
- 168 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q4 2022, down from 184 in Q3 2022.
- Funds reported $885M of Avid Bioservices, Inc. Common Stock stock for Q4 2022, down 28% quarter-over-quarter.
- 14 funds opened new Avid Bioservices, Inc. Common Stock positions in Q4 2022 and 26 closed out, a net change of -12 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q4 2022 was T. Rowe Price Investment Management, an estimated $30.1M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q4 2022 was Fidelity Investments, an estimated $51.4M sold.
Based on aggregated 13F filings for Q4 2022.